『Pharmacy Podcast Network』のカバーアート

Pharmacy Podcast Network

Pharmacy Podcast Network

著者： Pharmacy Podcast Network
無料で聴く

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.


PPN is a division of RxPR, LLC. Copyright 2026

2026 Pharmacy Podcast Network (TM) 政治・政府 日次 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Pharmacists and Advocacy for Patients in Pain | TWIRx

    Pharmacists and Advocacy for Patients in Pain | TWIRx
    2026/08/21
    Pharmacists and Advocacy for Patients in Pain Friday, August 21, 2026 What happens when patients living with chronic pain, their advocates, and the pharmacists responsible for dispensing opioid medications view the same healthcare system from very different perspectives? This special episode of This Week in Pharmacy brings together the Doctor Patient Forum’s founders, Claudia A. Merandi and Bev C. Schechtman, with pharmacist and nationally recognized pharmacy advocate Dr. Shane Jerominski, PharmD—better known as “The Accidental Pharmacist.” The discussion follows a wave of social-media debate surrounding Claudia’s use of the term “Harmacists,” which prompted responses from hundreds of pharmacists who felt the label misrepresented their professional responsibilities and the legal restrictions under which they practice. Rather than allow that controversy to deepen the divide, TWIRx created an opportunity for direct, respectful conversation. The purpose of this episode is to help pain-patient advocates better understand the limits pharmacists face when dispensing opioids—and to identify opportunities for pharmacists and patient organizations to advocate together for safe, compassionate and uninterrupted pain care. Five Legal and Supply-Chain Realities Affecting Opioid Dispensing Pharmacists have a federal “corresponding responsibility.” Under 21 CFR §1306.04, a controlled-substance prescription must be issued for a legitimate medical purpose. Pharmacists share legal responsibility with prescribers for determining whether a prescription is valid. Knowingly filling an illegitimate prescription may expose the pharmacist to federal penalties and professional discipline. Review the federal regulation.Schedule II prescriptions must satisfy strict requirements. Federal law generally requires a valid written or compliant electronic prescription before a Schedule II opioid may be dispensed. Emergency oral prescriptions are permitted only under limited conditions and require prescriber follow-up documentation.Schedule II opioid prescriptions cannot be refilled. Under federal law, every additional dispensing generally requires a new prescription. Partial fills are allowed only under specific circumstances, documentation requirements and time limits. Pharmacists cannot simply extend or refill opioid therapy when a patient or prescriber requests it.State laws add another layer of requirements. Depending on the state, pharmacists may have to verify prescriber authority, review prescription-monitoring information, validate electronic or security-form requirements, confirm identification, document partial fills, or comply with state-specific dispensing limitations. For example, California requires controlled-substance prescriptions to meet defined security and validity standards. California Board of Pharmacy guidance.Wholesaler monitoring can restrict a pharmacy’s opioid supply. DEA-registered distributors must identify and report suspicious controlled-substance orders under 21 CFR §1301.74. National wholesalers therefore operate monitoring programs that may delay, limit or suspend shipments based on ordering patterns, geography, drug mix and internal thresholds. These controls are imposed upstream and can leave a pharmacy unable to obtain medication—even when the pharmacist believes a prescription is clinically and legally appropriate. Review the federal distributor requirements. These examples are not exhaustive. Pharmacists must navigate overlapping federal law, DEA requirements, state pharmacy and controlled-substance laws, prescription-monitoring systems, employer policies, payer rules, wholesaler restrictions and professional standards. Requirements also vary by state and by the circumstances surrounding an individual prescription. The Central Question How can pain-patient advocates and pharmacists move beyond blame and work together to address the policies, supply restrictions, staffing conditions and regulatory pressures that can interfere with appropriate care? This conversation explores: Why patients may interpret a refusal or delay as judgment, discrimination or abandonmentWhy pharmacists cannot treat a valid prescriber signature as automatic authorization to dispenseHow PDMP and risk-scoring information can influence clinical decisionsThe effect of corporate policies and wholesaler ordering controlsThe difference between professional judgment and stigmaThe communication failures that damage trust between patients, prescribers and pharmacistsHow advocacy organizations and pharmacists can pursue policy reform togetherWhy patients deserve clear explanations, respectful treatment and continuity-of-care planningHow pharmacists can remain vigilant without losing empathy for people living with pain About the Doctor Patient Forum The Doctor Patient Forum, founded by Claudia A. Merandi and Bev C. Schechtman, combines healthcare education, research, digital influence and patient ...
    続きを読む 一部表示
    1 時間 10 分
  • Are You Covered? A Liability Insurance Primer for Compounders | Essential: The Pharmacy Compounding Podcast

    Are You Covered? A Liability Insurance Primer for Compounders | Essential: The Pharmacy Compounding Podcast
    2026/08/21

    This episode looks at some smart ways to regulate pharmacy when it comes to med spas and pop-up clinics — ways that won’t cut patients off from their meds. We also look at the latest news on the thyroid-extract front, what’s happening with peptide compounding, and a bill in California that could bode well for pharmacists nationwide. Then we talk with Kristen Jones, PharmD, from Pharmacists Mutual about how insurance companies view compounding, and why compounders are taking a bigger risk than they might realize if they’re compounding peptides. Pharmacists Mutual: https://pmuw.com Join APC: a4pc.org/join Stay up to date on these topics and more at: a4pc.org/news
    続きを読む 一部表示
    31 分
  • 2026 Cencora ThoughtSpot Rewind | Part Two

    2026 Cencora ThoughtSpot Rewind | Part Two
    2026/08/20

    Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!

    In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/

    In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from:

    Scott Lake - Rx.co

    Kaley Lester - Outcomes

    Nicholas Turos - Cencora

    Janet Parrish - Adair Drug; Colombia, KY

    Kaushal Patel - Apollo Pharmacy; Savannah, GA

    Bianca Bradshaw - Elmore Pharmacy; Red Bluff, CA

    Zackary Levine - Cencora
    続きを読む 一部表示
    39 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません